Butyric Acid

Butyric Acid

SCHEMBL381472

CCCC(=O)O.O=c1ccc2nc3ccc(O)cc3oc-2c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 0.74
CYP1A2 P05177 1/20 0.56
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
USP2 O75604 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
PLEC Q15149 1/20 0.40
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
ESRRB O95718 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexanoate SCHEMBL21043913 0.92 APP (0.70) APPCYP1A2KDM4EALDH1A1GLA
Propionic Acid SCHEMBL21043899 0.92 APP (0.80) APPCYP1A2USP2MEN1POLB
Propionic Acid SCHEMBL21043901 0.92 APP (0.80) APPCYP1A2USP2MEN1POLB
Octanoic Acid SCHEMBL21043903 0.91 APP (0.68) APPCYP1A2KDM4EALDH1A1GLA
Decanoic Acid SCHEMBL6708176 0.91 APP (0.68) APPCYP1A2KDM4EALDH1A1GLA
Levulinic Acid SCHEMBL8512310 0.90 APP (0.73) APPCYP1A2KDM4EALDH1A1GLA
Alcohol SCHEMBL6810203 0.88 APP (0.86) APPCYP1A2USP2MEN1POLB
Acetic Acid SCHEMBL233000 0.88 APP (0.86) APPCYP1A2USP2MEN1POLB
Bromoacetic Acid SCHEMBL1896727 0.87 APP (0.80) APPCYP1A2USP2MEN1POLB
Gamma-Aminobutyric Acid SCHEMBL21043922 0.86 APP (0.71) APPCYP1A2KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4677362-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM Elleon Biotech Limited (HK) 2026-01-14 EP claimed
WO-2025062323-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM ELLEON BIOTECH LIMITED (CN) 2025-03-27 WO claimed
US-20210371899-A1 METHOD AND KIT FOR PESTICIDES DETECTION, AND PLASMID, BACULOVIRUS, CELL AND METHOD OF PREPARING THE SAME FOR PESTICIDE DETECTIONS ACADEMIA SINICA (TW) 2021-12-02 US claimed
US-20260117209-A1 MUTATIONS FOR IMPROVING ACTIVITY AND THERMOSTABILITY OF PETASE ENZYMES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2026-04-30 US disclosed
EP-4677362-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM Elleon Biotech Limited (HK) 2026-01-14 EP disclosed
EP-4673163-A2 PROTEINS THAT INHIBIT CYCLIC-OLIGONUCLEOTIDE-BASED ANTI-PHAGE SIGNALING SYSTEM (CBASS) The Regents of the University of California (US) 2026-01-07 EP disclosed
US-12385917-B2 Methods and compositions for tracking vegetation COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2025-08-12 US disclosed
WO-2025062323-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM ELLEON BIOTECH LIMITED (CN) 2025-03-27 WO disclosed
US-20250092014-A1 COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE METREA BIOSCIENCES INC (US) 2025-03-20 US disclosed
WO-2024182314-A2 PROTEINS THAT INHIBIT CYCLIC-OLIGONUCLEOTIDE-BASED ANTI-PHAGE SIGNALING SYSTEM (CBASS) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-09-06 WO disclosed
US-20240026333-A1 STABILITY AND ACTIVITY OF ENZYMES BY IMMOBILIZATION THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2024-01-25 US disclosed
US-7227158-B1 Stick-on self-indicating instant radiation dosimeter JP LABS, INC. (US) 2007-06-05 US disclosed
WO-2007041689-A2 METHODS OF SITE-SPECIFIC LABELING OF MOLECULES AND MOLECULES PRODUCED THEREBY PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-04-12 WO disclosed
US-7172877-B2 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-02-06 US disclosed
US-20060145091-A1 Self indicating radiation alert dosimeter JP LABORATORIES INC. 2006-07-06 US disclosed
EP-1599744-A2 SELF-INDICATING RADIATION ALERT DOSIMETER JP LABORATORIES, INC. (US) 2005-11-30 EP disclosed
US-20050233389-A1 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-10-20 US disclosed
US-20040209317-A1 Methods and compositions for peptide and protein labeling MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-10-21 US disclosed
WO-2004077097-A2 SELF-INDICATING RADIATION ALERT DOSIMETER JP LABORATORIES INC. (US) 2004-09-10 WO disclosed
US-4716222-A CHROMOGENS, SPECTROPHOTOMETRY HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233389-A1 Methods and compositions for peptide and protein labeling HLCS, BTD, QPCTL APP 99/4885CYP1A2 4803/4885KDM4E 3349/4885
US-20260117209-A1 MUTATIONS FOR IMPROVING ACTIVITY AND THERMOSTABILITY OF PETASE ENZYMES UCHL3, UCHL1, ESD APP 471/4885CYP1A2 718/4885KDM4E 483/4885
US-20250092014-A1 COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE LPL, LIPA, PNLIP APP 744/4885CYP1A2 973/4885KDM4E 4122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.